Health ❯ Healthcare ❯ Immunotherapy

Cancer Immunotherapy

mRNA-based Immunotherapy Neoantigen Vaccines Nivolumab Vaccine Development KRAS-targeted Therapies Neoantigens Immune-Independent Therapies Intratumoral Therapy Tumor-Associated Macrophages MHC Class II Targeted Therapy HER2 Positive Breast Cancer

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

Researchers report preclinical evidence for a combined immune‑endocrine regimen that reverses resistance in ER‑positive models.

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Pre-Surgery Nivolumab and Chemotherapy Improve Five-Year Survival in Operable Lung Cancer